Resonance Raman and surface-enhanced Raman spectroscopy were employed to study the interaction of hypericin with human serum albumin. The identification of the binding place for hypericin as well as the model for albumin−hypericin complex are presented. In this model hypericin interacts with tryptophan placed in II A subdomain of albumin. This interaction reflects (i) a change of the hydrophobicity of the tryptophan environment, (ii) the formation of an H-bond between the carbonyl group of hypericin and N1−H group of tryptophan, leading to a protonated-like carbonyl in the drug, (iii) a decrease of the strength of H bonding at the N1−H site of tryptophan, and (iv) a change of the tryptophan side-chain conformation.
No takes yet. Share an insight, caveat, or question.
Miškovský et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: